Historical record - last NADAC effective date: 1/10/2018
Product Information
HYDROMORPHONE HCL ER 32 MG TAB is a generic product labeled by Padagis US LLC, priced at $40.1024 per EA under NDC 00574029701. Its NADAC has been published 1 times since Jan 10, 2018.
FDA first approved this application on Apr 6, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the hydromorphone hydrochloride market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
32 mg/1
Manufacturer
Padagis US LLCNDC
00574029701
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
1/10/2018
Active Ingredients
HYDROMORPHONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204278FDA Approved
4/6/2015
TE Code
AB
On Market Since
5/22/2015
Pharmacological Classes
Price Statistics
The NADAC for HYDROMORPHONE HCL ER 32 MG TAB has been published 1 times since Jan 10, 2018. The table below summarizes its recorded NADAC range and movement.
| Current price | $40.1024 per EA |
|---|---|
| All-time high | $40.1024 (Jan 10, 2018) |
| All-time low | $40.1024 (Jan 10, 2018) |
| Median price | $40.1024 |
| Average price | $40.1024 |
| Weeks tracked | 1 |
| Tracking since | Jan 10, 2018 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
N/A
3Y
N/A
5Y
N/A
All
N/A
Last surveyed Jan 10, 2018 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the hydromorphone hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of HYDROMORPHONE HCL ER 32 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for HYDROMORPHONE HCL ER 32 MG TAB, manufactured by Padagis US LLC, is $40.1024 per EA (NDC 00574029701), effective Jan 10, 2018.
What are the highest and lowest recorded NADAC prices for HYDROMORPHONE HCL ER 32 MG TAB?
Since Jan 10, 2018, the NADAC for HYDROMORPHONE HCL ER 32 MG TAB has ranged from a low of $40.1024 (Jan 10, 2018) to a high of $40.1024 (Jan 10, 2018), with a median of $40.1024 per EA.
Are there cheaper alternatives to HYDROMORPHONE HCL ER 32 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of HYDROMORPHONE HCL ER 32 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures HYDROMORPHONE HCL ER 32 MG TAB?
HYDROMORPHONE HCL ER 32 MG TAB (NDC 00574029701) is labeled by Padagis US LLC, and CMS classifies it as a generic product.